Company: CDT
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001246
Chunk: 276

Company: CDT Equity Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 2
Chunk 276
---
  
     -  
     1,632  
     -  
     -  
     1,632 
  
    Foreign currency translation adjustment 
     -  
     -  
     -  
     -  
     3  
     3 
  
    Net loss 
     -  
     -  
     -  
     (17,802) 
     -  
     (17,802)
  
    Balance at December 31, 2024 
     1,384,801  
    $14  
    $21,880  
    $(29,101) 
    $414  
    $(6,793)
  
    Balance 
     1,384,801  
    $14  
    $21,880  
    $(29,101) 
    $414  
    $(6,793)

The
accompanying notes are an integral part of these consolidated financial statements. 

F-6

CONDUIT
PHARMACEUTICALS INC.

CONSOLIDATED
STATEMENTS OF CASH FLOWS

(in
thousands)

    2024  
    2023 

    Year Ended December 31, 

    2024  
    2023 
  
    Cash flows from operating activities: 

    Net loss 
    $(17,802) 
    $(535)
  
    Adjustments to reconcile net loss to net cash used in operating activities: 

    Gain on change in fair value of Cizzle option 
     -  
     (1,280)
  
    Gain on change in fair value of Vela option 
     -  
     (970)
  
    Loss on issuance of Vela option 
     -  
     987 
  
    Change in reserve for related party uncollectible loan 
     -  
     (240)
  
    Loss on debt extinguishment, net 
     707  
     - 
  
    Loss on related party loan forgiveness 
     -  
     12 
  
    Realized gain on short-term investments 
     (8) 
     - 
  
    Unrealized foreign exchange gain 
     13  
     (39)
  
    Loss (gain) on change in fair value of convertible notes payable 
     (2,018